GlassScriptPhysician profile
Logan Wells Huff
NPI 1538689807
$26,068.16
in general payments reported to CMS, 2019-2025
10 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,584 · 2020: $3,927 · 2021: $1,554 · 2022: $6,367 · 2023: $11K · 2024: $390 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,738 · Consulting Fee: $2,600 · Food and Beverage: $1,708 · Travel and Lodging: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,737.50 |
| Consulting Fee | $2,600.00 |
| Food and Beverage | $1,707.67 |
| Travel and Lodging | $1,590.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,569.21 | 2022-2025 | Acufex, Spatial Frame |
| Peerless Surgical INC. | $7,043.43 | 2019-2021 | |
| Vericel Corporation | $2,634.96 | 2023 | Maci |
| Medical Device Business Services, INC. | $1,354.03 | 2019-2023 | Dynacord |
| Arthrex, INC. | $1,298.34 | 2023 | |
| Stryker Corporation | $846.75 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, T2 Alpha |
| Depuy Synthes Sales INC. | $484.80 | 2019-2023 | Gryphon Orthocord |
| Kairos Surgical INC | $342.45 | 2023 | |
| Zimmer Biomet Holdings, INC. | $314.36 | 2022 | |
| Miach Orthopaedics, INC. | $179.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.